Literature DB >> 27396403

Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development.

Soodabeh Saeidnia, Ahmad R Gohari, Azadeh Manayi1.   

Abstract

Pharmacognosy is a science, which study natural products as a source of new drug leads and effective drug development. Rational and economic search for novel lead structures could maximize the speed of drug discovery by using powerful high technology methods. Reverse pharmacognosy, a complementary to pharmacognosy, couples the high throughput screening (HTS), virtual screening and databases along with the knowledge of traditional medicines. These strategies lead to identification of numerous in vitro active and selective hits enhancing the speed of drug discovery from natural sources. Besides, reverse pharmacology is a target base drug discovery approach; in the first step, a hypothesis is made that the alteration of specific protein activity will produce beneficial curative effects. Both, reverse pharmacognosy and reverse pharmacology take advantages of high technology methods to accomplish their particular purposes. Moreover, reverse pharmacognosy effectively utilize traditional medicines and natural products as promising sources to provide new drug leads as well as promote the rational use of them by using valuable information like protein structure databases and chemical libraries which prepare pharmacological profile of traditional medicine, plant extract or natural compounds.

Mesh:

Substances:

Year:  2016        PMID: 27396403     DOI: 10.2174/1389201017666160709200208

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

Review 1.  Alternative Animal and Non-Animal Models for Drug Discovery and Development: Bonus or Burden?

Authors:  Irlan Almeida Freires; Janaina de Cássia Orlandi Sardi; Ricardo Dias de Castro; Pedro Luiz Rosalen
Journal:  Pharm Res       Date:  2016-11-17       Impact factor: 4.200

2.  Protein engineering: Redirecting membrane machinery.

Authors:  Kalistyn Burley; Celia W Goulding
Journal:  Nat Chem Biol       Date:  2017-08-18       Impact factor: 15.040

3.  Icaritin inhibits CDK2 expression and activity to interfere with tumor progression.

Authors:  Chao Zhang; Xin Wang; Chuanbao Zhang
Journal:  iScience       Date:  2022-08-22

4.  HPLC Analysis and Skin Whitening Effects of Umbelliprenin-containing Extracts of Anethum Graveolens, Pimpinella Anisum, and Ferulago Campestris.

Authors:  Vito Alessandro Taddeo; Francesco Epifano; Francesca Preziuso; Serena Fiorito; Nicolas Caron; Arnaud Rives; Philippe de Medina; Marc Poirot; Sandrine Silvente-Poirot; Salvatore Genovese
Journal:  Molecules       Date:  2019-01-30       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.